论文部分内容阅读
乳腺导管原位癌(DCIS)一直是研究的热点之一,近年来随着研究的不断深入,对其认识发生了很大变化。由于乳腺检查方法的改进,乳腺DCIS的检出率已明显增加。目前,乳腺DCIS缺乏统一的取材和病理报告规范。不同单位因标本取材的差异,其确切诊断受到限制;因DCIS的组织形态学多样又涉及分级,病理报告也没有标准化的要求。故本文结合文献,提出对乳腺DCIS取材的诊断标准化及相关问题的认识。
Ductal ductal carcinoma in situ (DCIS) has been one of the hot spots in the research. In recent years, as the research progresses, great changes have taken place in its cognition. Due to the improvement of the method of breast examination, the detection rate of breast DCIS has increased significantly. Currently, DCIS lacks a uniform guideline for both material and pathology. Different units due to differences in the sample drawn, the exact diagnosis is limited; because DCIS histological diversity and involve grading, pathological reports nor standard requirements. Therefore, this article combined with the literature, put forward the DCIS diagnosis of breast normalization and related issues.